Cell and Gene Therapy Insights Webinars

CELL AND GENE THERAPY INSIGHTS

Learn how to design a simplified, cost-effective LVV manufacturing workflow

Learn how to design a simplified, cost-effective LVV manufacturing workflow

Nicole Votaw, Thomas Robert, Shameer Subratty

Optimizing iPSC-derived cell therapy development

Optimizing iPSC-derived cell therapy development

Future-proofing gene therapy: scalable AAV solutions and non-viral innovations

Future-proofing gene therapy: scalable AAV solutions and non-viral innovations

Strategic human raw material selection for cell therapy manufacturing

Strategic human raw material selection for cell therapy manufacturing

Daniel Benitez-Ribas

Cell therapy clinical translation: ensuring speed to clinic while mitigating risk

Cell therapy clinical translation: ensuring speed to clinic while mitigating risk

Shreya Shukla, Richard Dennett, Steffany Dunn

Exploring scalable, data-driven AAV manufacturing to achieve high yield and quality across serotypes

Exploring scalable, data-driven AAV manufacturing to achieve high yield and quality across serotypes

Xiaojun Liu, Chris Brown, Yeonji Kim

Digitization: the end-to-end solution for the decentralization of advanced therapies

Digitization: the end-to-end solution for the decentralization of advanced therapies

Emmanuel Casasola, Annie Prescott, Joseph Higdon

Streamline disease modeling and therapeutic discovery with targeted viral vectors

Streamline disease modeling and therapeutic discovery with targeted viral vectors

Abhilasha Gupta

Commercialization of CAR-T therapy in New Zealand: clinical insights & scalable manufacturing

Commercialization of CAR-T therapy in New Zealand: clinical insights & scalable manufacturing

Tamara Laskowski, Lawrence Cooper

Exploring key regulatory considerations to ensure patient safety in the gene therapy space

Exploring key regulatory considerations to ensure patient safety in the gene therapy space

L Shaw, C Le Bec, M Orio et al

Exploring the advantages of ready-to-use lipid-based gene delivery for gene-modified cell therapy

Exploring the advantages of ready-to-use lipid-based gene delivery for gene-modified cell therapy

Chesney Michels, Claire Guéguen

Enabling early AAV characterization: the role of mass photometry in upstream process development

Enabling early AAV characterization: the role of mass photometry in upstream process development

Maria Jacintha Victoria

Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach

Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach

Alex Lei, Sabrina Carmichael

Making robust choices: evaluating materials in your AAV process

Making robust choices: evaluating materials in your AAV process

Michael Bodo, Birgit Rogell

Combining CRISPR and transposon-based technologies for improved sdAb-based CAR-T therapies

Combining CRISPR and transposon-based technologies for improved sdAb-based CAR-T therapies

Begoña Diez Cabezas, Juan Roberto Rodriguez-Madoz

Optimizing plasmid DNA purification: strategies for reliable and expandable processes

Optimizing plasmid DNA purification: strategies for reliable and expandable processes

Christy Franco, Jasmina Puc

Non-viral GMP manufacturing for engineered cells at clinical and commercial scale

Non-viral GMP manufacturing for engineered cells at clinical and commercial scale

Leif Anderson, Chris Abraham

AAV production and purification: key steps from design to GMP readiness

AAV production and purification: key steps from design to GMP readiness

Goutham Ganjam, Florian Leseigneur, Emily Jackson-Holmes

1
2
3
4
5
6
7
8
9
10
...
>
>>